Clinical Trial Update: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update reports substantially improved cure rates for high-risk BRCA1-like breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING